trending Market Intelligence /marketintelligence/en/news-insights/trending/HMXQTdfRsBOfefebniTXNw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Phylogica chief scientific officer resigns

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Phylogica chief scientific officer resigns

Phylogica Ltd. said Robert Hayes stepped down as the company's chief scientific officer, effective Dec. 24.

The company does not plan to name a replacement for Hayes in the near future.

Hayes has been acting as the company's chief scientific officer since June 2017.

Perth, Australia-based Phylogica provides drug discovery research and development services.